Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  


KOPRAN. Plunges 5%; BSE HEALTHCARE Index Up 0.3%
Thu, 14 Nov 14:27

KOPRAN. Plunges 5%; BSE HEALTHCARE Index Up 0.3%Image source: asbe/www.istockphoto.com

KOPRAN. share price has plunged 5% and is presently trading at Rs 228.0.

Meanwhile, the BSE HEALTHCARE index is at 42,577.4 (up 0.3%).

Among the top losers in the BSE HEALTHCARE index today are ASTRAZENECA PHARMA (down 5.4%) and J.B.Chemicals (down 2.6%).

GLAND PHARMA (up 3.4%) and FORTIS HEALTHCARE (up 3.1%) are among the top gainers today.

Over the last one year, KOPRAN. has moved down from Rs 230.1 to Rs 228.0, registering a loss of Rs 2.1 (down 0.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,042.6 to 42,577.4, registering a gain of 46.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 183.1%), SUVEN PHARMACEUTICALS (up 118.1%) and Glenmark Pharma (up 101.6%).

For Investors: Our Big Prediction

What About the Benchmark Indices?

The BSE Sensex is at 77,603.0 (down 0.1%).

The top losers among the BSE Sensex today are Hindustan Unilever (down 2.5%) and Power Grid Corp. (down 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 23,543.9 (down 0.1%). BPCL and Tata Consumer Products are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,259.5 to 77,603.0, registering a gain of 12,343.6 points (up 18.9%).

KOPRAN. Financial Update...

KOPRAN. net profit grew 300.1% YoY to Rs 111 million for the quarter ended June 2024, compared to a profit of Rs 28 million a year ago. Net sales rose 19.2% to Rs 1,394 million during the period as against Rs 1,170 million in April-June 2023.

For the year ended March 2024, KOPRAN. reported 87.1% increase in net profit to Rs 510 million compared to net profit of Rs 272 million during FY23. Revenue of the company grew 11.5% to Rs 6,146 million during FY24.

The current Price to earnings ratio of KOPRAN., based on rolling 12 month earnings, stands at 18.6.


Equitymaster requests your view! Post a comment on "KOPRAN. Plunges 5%; BSE HEALTHCARE Index Up 0.3%". Click here!